Ikeda, Japan

Mikao Mayama

This inventor holds 3 USPTO granted patents. Top assignee: Shionogi Company Limited. Active years: 1976-1984.


% Patents Active = 100.0

Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Ikeda, JA (1976)
  • Osaka, JP (1984)

Company Filing History:


Years Active: 1976-1984

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Mikao Mayama

Introduction

Mikao Mayama is a notable inventor based in Ikeda, Japan. He has made significant contributions to the field of antibiotics, holding a total of 3 patents. His work focuses on developing new antibiotics that are effective against various pathogenic microorganisms.

Latest Patents

Mikao Mayama's latest patents include Antibiotics PA-41746-B and C, which are new antibiotics exhibiting .beta.-lactamase inhibitory activity. These compounds are characterized by the formula wherein R is carboxymethylsulfinyl (PA-41746-B) or formylsulfinyl (PA-41746-C). They are useful as medicaments, veterinary drugs, and disinfectants for inhibiting the growth of both gram-positive and gram-negative pathogenic microorganisms. The process for preparing these antibiotics involves cultivating Streptomyces pluracidomyceticus in a suitable medium and isolating PA-41746-B and/or PA-41746-C from the culture broth. Additionally, he has developed antibiotic siomycin A derivatives produced by the reaction of siomycin A with a dicarboxylic acid. These derivatives exhibit excellent solubility characteristics compared to siomycin A and are also useful as medicaments.

Career Highlights

Mikao Mayama is associated with Shionogi Company Limited, where he continues to innovate in the field of antibiotic research. His work has been instrumental in advancing the development of new therapeutic agents that address critical health challenges.

Collaborations

Mikao has collaborated with notable colleagues such as Shinzo Matsuura and Kouichi Matsumoto, contributing to the advancement of antibiotic research and development.

Conclusion

Mikao Mayama's contributions to antibiotic innovation highlight his commitment to improving healthcare through scientific research. His patents reflect a dedication to developing effective treatments against harmful microorganisms.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…